Fontem co-invests in deep tech startups in health and environment, then actively pilots their growth between two rounds of financing — where value is created or destroyed.
No advisory without capital.
No capital without operations.
Fontem co-invests in deep tech startups, then actively pilots their growth between two rounds of financing — where value is created or destroyed. Not just a backer, not just an advisor: an operator with skin in the game.
Medtech, Healthtech, Biotech. We invest before revenue: a validated PoC and a structured regulatory path matter more than early sales.
Cleantech, deep green tech, energy transition. Projects rooted in impact reduction, with a demonstrated PoC and industrial or institutional partners in validation phase.
Invest first. Operate deep. Connect at the right moment.
We analyze the project, market and team in depth. Technical, commercial and regulatory due diligence. We only enter a deal if we believe in the potential and the execution capacity.
Term sheet, co-investment, next-round objectives defined together. We formalize the alignment of interests and set up the operational follow-up framework from day one.
The core of our engagement. Weekly to daily piloting on the value-creating levers: product execution, commercial traction, key hires, regulatory milestones, investor narrative.
When the file is ready — not before. Partner-level introductions, prepared over 6 to 12 months, calibrated for the right investor profiles. We support all the way to closing.
Breast cancer recurrence risk detection via PCR. A fully decentralized precision diagnostics approach.
Dental surgical robotics. Precision and repeatability for practitioners, directly in the operating room.
AI dedicated to medical writing. Accelerates the production of clinical and regulatory dossiers.
Intelligent voice hub for care. Simplifies coordination between patients and care teams through voice.
Real-time ENT surgical navigation. Reduces intraoperative risks through augmented imaging.
Certification platform for software medical devices (SaMD). Speeds up regulatory-compliant market entry.
Stealth modeClinical trials supply chain. Optimizes sourcing and logistics of studies to accelerate execution.
When we identify an opportunity without a suitable lead, Fontem initiates the project, recruits co-founders and pilots the launch.
In progress
Serial entrepreneur and investor. Co-founder of two startup studios, +10 fundraises supported. Pilots operational execution and financing.
PhD in chemistry, co-founder of ANMI (exit to Telix Pharmaceuticals). Regulatory, patents and scientific evaluation expert on every health deal.
Co-founder and director of ANMI (exit to Telix Pharmaceuticals). Covers industrialization and scale-up on the health vertical.
Liège is our starting point — a dense scientific and industrial ecosystem, anchored by the University of Liège, the CHU hospital, and a tradition of DeepTech innovation. But our deals, partners and investors do not stop at the borders.
Before you write, take a moment to prepare :
No need for a deck at this stage. A clear message beats a polished pitch.
Response within 5 business days.